Jeffrey A Toretsky

Title: Innovations of Jeffrey A. Toretsky

Introduction

Jeffrey A. Toretsky is a prominent inventor based in Silver Spring, MD, known for his significant contributions to the field of cancer research. With a total of seven patents to his name, he has made remarkable strides in developing therapies for bone and connective tissue cancers.

Latest Patents

Among his latest patents, one notable invention is related to CD99 inhibitors and their uses. This patent outlines methods for treating bone or connective tissue cancer by administering an effective amount of a CD99 inhibitor. The compound described in the patent includes specific chemical formulas that target cancer cells effectively. Another significant patent focuses on targeting EWS-FLI1 as an anti-tumor therapy. This invention provides peptides and compounds that act as EWS-FLI1 protein inhibitors, which are particularly useful in treating Ewing's sarcoma family of tumors. The patent also details methods for preparing these compounds and assays for identifying EWS-FLI1 protein inhibitors.

Career Highlights

Jeffrey A. Toretsky is affiliated with Georgetown University, where he continues to advance his research and innovation in cancer therapies. His work has garnered attention in the scientific community, contributing to the understanding and treatment of complex cancers.

Collaborations

He collaborates with esteemed colleagues, including Milton L. Brown and Yali Kong, who share his commitment to advancing cancer research and developing effective treatments.

Conclusion

Jeffrey A. Toretsky's innovative work in cancer research, particularly through his patents on CD99 inhibitors and EWS-FLI1 protein inhibitors, showcases his dedication to improving treatment options for patients. His contributions are vital in the ongoing fight against cancer.